Peptide variant and the fusion protein and use thereof

TW202633906APending Publication Date: 2026-08-16HANSOH BIO LLC +2
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114137777
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-06-26
Filing Date
2025-09-30
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072664_001
    Figure TWG2TA001072664_001
  • Figure TWG2TA001072664_002
    Figure TWG2TA001072664_002
  • Figure TWG2TA001072664_003
    Figure TWG2TA001072664_003
Patent Text Reader

Abstract

The present application relates to a peptide variant and a fusion protein and use thereof. Specifically, provided are a wild-type B-cell maturation antigen CRD (cysteine-rich domain), a mutation sequence thereof, and a fusion protein comprising the peptide and use thereof.
Need to check novelty before this filing date? Find Prior Art